Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippings.
We describe 2 cases of immunocompetent males with acute community-acquired invasive pulmonary aspergillosis developing shortly after spreading bark chippings. One patient with a fatal outcome was initially diagnosed as allergic alveolitis rather than infection and received steroid treatment illustrating the obvious challenges in the differential diagnosis between these disease entities.
Arendrup
Maiken Cavling
MC
Unit of Mycology and Parasitology, Statens Serum Institute, Copenhagen, Denmark. mad@ssi.dk
O'driscoll
B Ronan
BR
Petersen
Eskild
E
Denning
David W
DW
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000175:diagnosis* / Q000382:microbiology* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D007121:Immunocompetence; D017964:Itraconazole / Q000627:therapeutic use; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D024301:Plant Bark / Q000382:microbiology*
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D017964:Itraconazole; D000666:Amphotericin B